Jong Young Choi

1.3k total citations
33 papers, 1.1k citations indexed

About

Jong Young Choi is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Jong Young Choi has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 11 papers in Epidemiology and 9 papers in Cancer Research. Recurrent topics in Jong Young Choi's work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Jong Young Choi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Jong Young Choi collaborates with scholars based in South Korea, United States and China. Jong Young Choi's co-authors include Si Hyun Bae, Seung Kew Yoon, Jeong Won Jang, Jung Hyun Kwon, Ho Jong Chun, Kyu Won Chung, Myeong Jun Song, Hong Seok Jang, Byung Ock Choi and Ji Yoon Kim and has published in prestigious journals such as Journal of Hepatology, Frontiers in Immunology and World Journal of Gastroenterology.

In The Last Decade

Jong Young Choi

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong Young Choi South Korea 18 899 397 315 178 171 33 1.1k
Marco Bongini Italy 15 1.4k 1.6× 887 2.2× 659 2.1× 152 0.9× 387 2.3× 26 1.8k
Á. Chopitea Spain 17 531 0.6× 149 0.4× 302 1.0× 58 0.3× 489 2.9× 43 1.0k
Hirokazu Chishina Japan 18 900 1.0× 378 1.0× 199 0.6× 163 0.9× 225 1.3× 44 1.1k
Maria Del Carmen Ayuso Spain 4 1.7k 1.9× 911 2.3× 559 1.8× 193 1.1× 194 1.1× 5 1.8k
S Yamasaki Japan 16 1.4k 1.5× 529 1.3× 841 2.7× 209 1.2× 603 3.5× 30 1.8k
Keun Soo Ahn South Korea 20 499 0.6× 268 0.7× 660 2.1× 181 1.0× 481 2.8× 66 1.2k
Miho Kanda Japan 9 567 0.6× 200 0.5× 282 0.9× 139 0.8× 187 1.1× 15 759
Sheung-Tat Fan Hong Kong 6 723 0.8× 403 1.0× 412 1.3× 192 1.1× 189 1.1× 6 1.0k
Su Jung Shim South Korea 14 228 0.3× 75 0.2× 303 1.0× 145 0.8× 294 1.7× 34 819
Liming Wang China 15 292 0.3× 132 0.3× 252 0.8× 101 0.6× 197 1.2× 62 663

Countries citing papers authored by Jong Young Choi

Since Specialization
Citations

This map shows the geographic impact of Jong Young Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Young Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Young Choi more than expected).

Fields of papers citing papers by Jong Young Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Young Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Young Choi. The network helps show where Jong Young Choi may publish in the future.

Co-authorship network of co-authors of Jong Young Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Young Choi. A scholar is included among the top collaborators of Jong Young Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Young Choi. Jong Young Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Han, Ji Won, Soon Kyu Lee, Heechul Nam, et al.. (2024). Differential HBV replicative markers and covalently closed circular DNA transcription in immune‐active chronic hepatitis B with and without HBeAg. Liver International. 44(10). 2753–2762. 2 indexed citations
3.
Kim, Dong Hwan, Bohyun Kim, Jong Young Choi, et al.. (2024). RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab. European Radiology. 35(2). 684–694. 2 indexed citations
4.
Han, Ji Won, Soon Kyu Lee, Hyun Yang, et al.. (2024). Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma. Liver Cancer. 14(1). 1–13. 3 indexed citations
5.
Nam, Heechul, Jaejun Lee, Ji Won Han, et al.. (2023). Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study. Liver Cancer. 13(4). 413–425. 7 indexed citations
6.
Kwon, Min, Ji Hoon Kim, Ji Won Han, et al.. (2023). Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data. Frontiers in Oncology. 13. 1142661–1142661. 3 indexed citations
7.
Song, Myeong Jun, Si Hyun Bae, June Sung Lee, et al.. (2016). Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. The Korean Journal of Internal Medicine. 31(2). 242–252. 41 indexed citations
8.
Kim, Do Young, Beom Jin Park, Yun Hwan Kim, et al.. (2013). Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma. American Journal of Clinical Oncology. 38(5). 495–501. 33 indexed citations
9.
Song, Myeong Jun, Si Hyun Bae, Sung Won Lee, et al.. (2013). 18F-Fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 40(6). 865–873. 44 indexed citations
10.
Choi, Jong Young. (2013). Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World Journal of Gastroenterology. 19(3). 339–339. 95 indexed citations
11.
Yoo, Sun Hong, Jong Young Choi, Jeong Won Jang, et al.. (2013). Gd-EOB-DTPA-Enhanced MRI is Better than MDCT in Decision Making of Curative Treatment for Hepatocellular Carcinoma. Annals of Surgical Oncology. 20(9). 2893–2900. 31 indexed citations
12.
Song, Do Seon, Jong Young Choi, Sun Hong Yoo, et al.. (2013). DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study. Gut and Liver. 7(1). 89–95. 21 indexed citations
13.
Song, Myeong Jun, Si Hyun Bae, Ie Ryung Yoo, et al.. (2012). Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.. PubMed. 18(25). 3215–22. 38 indexed citations
14.
Han, Kwang‐Hyub, Sheng-Long Ye, Jong Young Choi, et al.. (2011). Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia. Oncology. 81(Suppl. 1). 158–164. 98 indexed citations
15.
Choi, Jong Young. (2011). Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea. Oncology. 81(Suppl. 1). 141–147. 23 indexed citations
16.
17.
Song, Myeong Jun, Chung-Hwa Park, Jin-Dong Kim, et al.. (2011). Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. 23(6). 521–527. 63 indexed citations
18.
Jang, Jeong Won, Gi Dae Kim, Wonhee Hur, et al.. (2009). Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis. Cancer Chemotherapy and Pharmacology. 65(6). 1029–1037. 23 indexed citations
19.
Woo, Hyun Young, Jeong Won Jang, Jong Young Choi, et al.. (2009). Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma. Scandinavian Journal of Gastroenterology. 45(3). 332–339. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Bongini Breakdown of academic impact, for papers by Á. Chopitea Breakdown of academic impact, for papers by Hirokazu Chishina Breakdown of academic impact, for papers by Maria Del Carmen Ayuso Breakdown of academic impact, for papers by S Yamasaki Breakdown of academic impact, for papers by Keun Soo Ahn Breakdown of academic impact, for papers by Miho Kanda Breakdown of academic impact, for papers by Sheung-Tat Fan Breakdown of academic impact, for papers by Su Jung Shim Breakdown of academic impact, for papers by Liming Wang
Rankless by CCL
2026